Merus (NASDAQ:MRUS – Get Rating) had its price objective lifted by equities research analysts at Citigroup from $30.00 to $38.00 in a research note issued on Wednesday, The Fly reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Citigroup’s target price would indicate a potential upside of 107.31% from the stock’s […]